Abstract
Considerable progress has been made recently in understanding the pathogenesis of pseudomonas keratitis including its adhesion, invasion and the role of the glycocalyx. Adhesion to epithelial cells has been shown in vitro to depend on pili but their relationship to the glycocalyx biofilm has yet to be explored. The actions of its toxins and proteases have been established by studying the effects of deletion mutants. However, in animal models pseudomonads have been unable to cause an invasive infection in the presence of an intact corneal epithelium and have required associated trauma. Why early necrosis of the cornea can occur in an immunocompetent individual is still not clear but may reflect the delayed access of polymorphonuclear cells (PMNs) in an avascular tissue. Whether the corneal necrosis that later occurs is then due to the PMNs or pseudomonas toxins is not established. Topical fortified gentamicin therapy remains the treatment of choice for early infection. The use of medical and surgical adjunctive therapy is often needed to cope with the complications of advanced disease and has been reviewed.
Similar content being viewed by others
Article PDF
References
Kreger AS . Pathogenesis of Pseudomonas aeruginosa Ocular Diseases. Rev Inf Dis 1983; 5 (supplement 5): S931–5.
Berk RS, Hazlett LD, Beisel KW . Genetic studies on resistant and susceptibility genes controlling the mouse cornea to infection with Ps. aeruginosa. Antibiot Chemother 1987; 39: 83–91.
Pollack M . The Virulence of Pseudomonas aeruginosa. Rev Inf Dis 1984; 6 (supplement 3): S617–26.
Ramphal R, McNiece MT, Polack FM . Adherence of Ps. aeruginosa to the injured cornea: a step in the pathogenesis of corneal infections. Ann Ophthalmol 1981; 13: 421–5.
Stern GA, Lubniewski A, Allen C . The interaction between Ps. aeruginosa and the corneal epithelium. Arch Ophthalmol 1985; 103: 1221–5.
Dart JK, Peacock JL, Hughes R, et al.. Bacterial colonisation of rabbit corneal epithelium. Invest Ophthalmol Vis Sci 1987; 28 (3): 174 (abstr).
Reichert RW, Das NE, Zam ZS . Adherence properties of Pseudomonas pili to epithelial cells of the human cornea. Curr Eye Res 1983; 2: 289–93.
Woods DE, Straus DC, Johanson WG, et al.. Factors influencing the adherence of Ps. aeruginosa to mammalian buccal epithelial cells. Rev Inf Dis 1983; (supplement 5): S846–51.
Paranchych W, Sastry PA, Volpel K, et al.. Fimbrae (pili): molecular basis of Ps. aeruginosa adherence. Clin Invest Med 1986; 9: 113–8.
Sato H, Okinaga K . Role of pili in the adherence of Ps. aeruginosa to mouse epidermal cells. Inf Immunol 1987; 55: 1774–8.
Holder IA, Naglich JG . Experimental studies of the pathogenesis of infections due to Ps. aeruginosa: immunization using divalent flagella preparations. J Traum 1986; 26: 118–22.
Pier GB . Pseudomonas aeruginosa surface polysaccharide vaccines. Antibiot Chemother 1985; 36: 157–67.
Laharrague PF, Corberand JX, Fillola G, et al.. In vitro effect of the slime of Ps. aeruginosa on the function of human polymorphonuclear neutro-phils. Inf Immunol 1984; 44: 760–2.
Gristina AG, Costerton JW . Bacterial adherence and the glycocalyx and their role in musculoskeletal infection. Ortho Clin N Am 1984; 15: 517–35.
Gristina AG, Oga M, Webb LX, et al.. Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science 1985; 228: 990–3.
Gristina AG, Costerton JW . Bacterial adherence to biomaterials and tissue. J Bone Joint Surg 1985; 67: 264–73.
Costerton JW, Lam J, Lam K, et al.. The role of the microcolony mode of growth in the pathogenesis of Ps. aeruginosa infections. Rev Inf Dis 1983; 5 (supplement 5): S867–73.
Slusher MM, Myrvik QN, Lewis JC, et al.. Extended-wear lenses, biofilm and bacterial adhesion. Arch Ophthalmol 1987; 105: 110–15.
Dart JKG, Grierson I, Peacock J, et al.. Ocular surface, contact lens and bacterial interactions: histochemistry of the colonised contact lens surface. Invest Ophthalmol Vis Sci 1988; 29: 231 (abstr).
Rayman S, Williams SA, Spencer PD, et al.. Impaired microvasculature hyperaemic response to minor skin trauma in type I diabetes. Br Med J 1986; 292: 1295–8.
Lory S, Tai PC . Biochemical and genetic aspects of Ps. aeruginosa virulence. Curr Top Microbiol Immunol 1985; 118: 53–69.
Hedstrom RC, Funk CR, Kaper JB, et al.. Cloning of a gene involved in regulation of exotoxin A expression in Ps. aeruginosa. Inf Immunol 1986; 51: 37–42.
Kawaharajo K, Homma JY . Pathogenesis of the mouse keratitis produced with Ps. aeruginosa. Jap J Exp Med 1975; 45: 515–24.
Ohman DE, Burns P, Iglewski BH . Corneal infections in mice with toxin A and elastase mutants of Ps. aeruginosa. J Inf Dis 1980; 142: 547–55.
Howe TR, Iglewski BH . Alkaline protease deficient mutants of Ps. aeruginosa; isolation and characterization in vitro and in a mouse eye model. Inf Immunol 1984; 43: 1058–63.
Kessler E, Blumberg S . Specific inhibitors of Ps. aeruginosa elastase as potential drugs for the treatment of Pseudomonas keratitis. Antibiot Chemother 1987; 39: 102–112.
Nicas IT, Iglewski BH . Production of elastase and other exoproducts by environmental isolates of Ps. aeruginosa. J Clin Microbiol 1986; 23: 967–9.
Hyndiuk RA . Experimental pseudomonas keratitis. Trans Am Ophthalmol Soc 1981; LXXIX: 541–624.
Twining SS, Lohr KM, Moulder JE . The immune system in experimental pseudomonas keratitis: model and early effects. Invest Ophthalmol Vis Sci 1986; 27: 507–15.
Chusid MJ, Davis SD . Polymorphonuclear leukocyte kinetics in experimentally induced keratitis. Arch Ophthalmol 1985; 103: 270–4.
Jones DB . Pathogenesis of bacterial and fungal keratitis. Trans Ophthalmol Soc UK 1978; 98: 367–71.
Steuhl K-P, Doring G, Henni A, et al.. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Invest Ophthalmol Vis Sci 1987; 28: 1559–68.
Laibson PR . Cornea and sclera. Arch Ophthalmol 1972; 88: 553–74.
Jones DB . Strategy for the initial management of suspected microbial keratitis. In: Symposium on medical and surgical diseases of the cornea. St Louis; CV Mosby, 1980: 86–119.
Clemons CS, Cohen EJ, Arentsen JJ, et al.. Pseudomonas ulcers following patching of corneal abrasions associated with contact lens wear. CLAO J 1987; 13: 161–4.
Roussel TJ, Osato MS, Robinson NM, et al.. Resistant pseudomonas keratitis. J Ocul Ther Surg 1984; 3: 136–8.
Jones DB . Decision-making in the management of microbial keratitis. Ophthalmology 1981; 88: 814–20.
Baum JL, Jones DB . Initial therapy of suspected microbial corneal ulcers. Surv Ophthalmol 1979; 24: 97–116.
Goldstein EJG, Citron DM, Bendon L, et al.. Potential of topical norfloxacin therapy: comparative in vitro activity against clinical ocular bacterial isolates. Arch Ophthalmol 1987; 105: 991–4.
Baum J . Treatment of bacterial ulcers of the cornea in the rabbit: a comparison of administration by eye drops and subconjunctival injections. Trans Am Ophthalmol Soc 1982; LXXX: 369–90.
Ogaard AR, Bjoro K, Bukholm G, et al.. Pseudomonas aeruginosa virulence factors: modifications by sub-inhibitory concentrations of carbenicillin or gentamicin. Acta Path Microbiol Immunol Scand Sect B 1986; 94: 63–8.
Seal DV, Strangeways JEM . Resistant pseudo-monads in a neurosurgical unit. Lancet 1975; i: 48.
Seal DV, Strangeways JEM . Temperature sensitivity and gentamicin resistance in Pseudomonas aeruginosa. Lancet 1975; ii: 501.
Clark RB, Janda JM, Bottone EJ . Phenotypic factors correlated with the absence of virulence among gentamicin resistant Pseudomonas aeruginosa strains. J Clin Microbiol 1984; 20: 235–8.
Bayer AS, Norman DC, Kim KS . Characterisation of impermeability variants of Pseudomonas aeruginosa isolated during unsuccessful therapy of experimental endocarditis. Antimicrob Agents Chemother 1987; 31: 70–75.
Bryan LE, Godfrey AJ, Schoffardt T . Virulence of Pseudomonas aeruginosa strains with mechanisms of microbial persistence for β lactam and aminoglycoside antibiotics in a mouse infection model. Can J Microbiol 1985; 31: 377–80.
Wise R . Antimicrobial agents: a widening choice. Lancet 1987; i: 1251–4.
Finch R . Anti-infectives. Br Med J 1988; 296: 261–4.
David SD, Sarff LD, Hyndiuk RA . Comparison of therapeutic routes in experimental pseudomonas keratitis. Am J Ophthalmol 1979; 87: 710–6.
Leibowitz HM, Ryan WJ, Kupferman A . Route of antibiotic administration in bacterial keratitis. Arch Ophthalmol 1981; 99: 1420–3.
Wilson LA . Acute bacterial infection of the eye; bacterial keratitis and endophthalmitis. Trans Ophthalmol Soc UK 1986; 105: 43–60.
Spence DJ, Schanzlin DJ . Corticosteroid therapy in infectious external ocular diseases. In Smolin G, Okumoto M (eds): Antimicrobial agents in ophthalmology. New York; Masson Pub Inc 1983: 87–94.
Leibowitz HM, Kupferman A . Topically administered corticosteroids: effect on antibiotic-treated bacterial keratitis. Arch Ophthalmol 1980; 98: 1287–90.
Coster DJ, Badenoch PR . Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis. Br J Ophthalmol 1987; 71: 96–101.
Stern GA, Okumoto M, Friedlander M, et al.. The effect of combined gentamicin-corticosteroid treatment on gentamicin-resistant pseudomonas keratitis. Ann Ophthalmol 1980; 12: 1011–4.
Smolin G, Okumoto M, Leong-Sit L . Combined gentamicin-tobramicin-corticosteroid treatment II. Effect on gentamicin-resistant pseudomonas keratitis. Arch Ophthalmol 1980; 98: 473–4.
Alfonso E, Kenyon KR, Ormerod D, et al.. Pseudomonas corneoscleritis. Am J Ophthalmol 1987; 103: 90–8.
Burstein NL . Corneal cytotoxicity of topically applied drugs, vehicles, and preservatives. Surv Ophthalmol 1980; 25: 15–30.
Mondino BJ, Brown SI, Rabin BS . Role of complement in corneal inflammation. Trans Ophthalmol Soc UK 1978; 98: 363–6.
Petrousos G, Guimaraes R, Giraud J, et al.. Antibiotics and corneal epithelial wound healing. Arch Ophthalmol 1983; 101: 1775–8.
Kirkness CM, Adams GGW, Dilly PN, et al.. Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology 1988; 95: 473–80.
Buxton JM, Fox ML . Conjunctival flaps in the treatment of refractory pseudomonas corneal abscess. Ann Ophthalmol 1986; 18: 315–8.
Mandlebaum S, Udell IJ . Tissue adhesives. In Abbott RL (ed): Surgical intervention in corneal and external diseases. Orlando Florida (USA); Grune and Stratton Inc 1987: 89–93.
Hyndiuk RA, Hull DS, Kinyoun JL . Free tissue patch and cyanoacrylate in corneal perforations. Ophthalmic Surg 1974; 5: 50–5.
Thiel H-J, Steuhl K-P, Doring G . Therapy of Pseudomonas aeruginosa eye infections. Antibiot Chemoiher 1987; 39: 92–101.
Malik SRK, Singh G . Therapeutic keratoplasty in Pseudomonas pyotyaneus corneal ulcers. Br J Ophthalmol 1971; 55: 326–30.
Fromer C, L'Esperance F . Argon laser phototherapy of pseudomonas corneal ulcers. Invest Ophthalmol Vis Sci 1971; 10: 1–8.
Welsh NH, Rauch AJ, Gaffin SL . Topical immunotherapy for pseudomonas keratitis in rabbits; use of antilipopolysaccharide plasma. Br J Ophthalmol 1984; 68: 828–32.
Rootman DS, Hobden JA, Jantzen JA, et al.. Iontophoresis of tobramycin for the treatment of experimental pseudomonas keratitis in the rabbit. Arch Ophthalmol 1988; 106: 262–5.
Kessler E, Spierer A, Blumberg S . Specific inhibition of Pseudomonas aeruginosa elastase injected intracorneally in rabbit eyes. Invest Ophthalmol Vis Sci 1983; 24: 1093–7.
Eiferman RA . Cryotherapy of pseudomonas keratitis and scleritis. Arch Ophthalmol 1979; 97: 1637–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dart, J., Seal, D. Pathogenesis and therapy of pseudomonas aeruginosa keratitis. Eye 2 (Suppl 1), S46–S55 (1988). https://doi.org/10.1038/eye.1988.133
Issue Date:
DOI: https://doi.org/10.1038/eye.1988.133
This article is cited by
-
Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome
Graefe's Archive for Clinical and Experimental Ophthalmology (2016)